Ariel Rubashkin

Ariel Rubashkin

Director/Board Member at ENDYMED LTD

46 year
Health Technology
Consumer Services
Finance

Profile

Ariel Rubashkin is an Independent Director at EndyMed Ltd.
and a Managing Director at Syneron GmbH.
He is also a Director at Allium Ltd., Truleaf Medical Ltd., and Allevetix Medical Ltd.
Mr. Rubashkin was previously the Chief Executive Officer at Allmed Solutions Ltd.
from 2014 to 2022 and the Global Vice President-Finance at Syneron Medical Ltd.
from 2007 to 2014.
He also worked as a Controller at Plastro Gvat.
Mr. Rubashkin holds an MBA from Tel-Aviv University and an undergraduate degree from the University of Haifa.

Ariel Rubashkin active positions

CompaniesPositionStart
ENDYMED LTD Director/Board Member 2021-01-04
Chief Executive Officer 2011-10-18
Allevetix Medical Ltd. Director/Board Member 2019-09-30
Truleaf Medical Ltd. Director/Board Member 2019-09-30
Allium Ltd. Director/Board Member 2019-09-30
All active positions of Ariel Rubashkin

Former positions of Ariel Rubashkin

CompaniesPositionEnd
ALLMED SOLUTIONS LTD Chief Executive Officer 2022-02-27
SYNERON MEDICAL LTD. Corporate Officer/Principal 2013-12-31
Comptroller/Controller/Auditor 1990-01-01
See the detail of Ariel Rubashkin's experience

Training of Ariel Rubashkin

Tel-Aviv University Masters Business Admin
University of Haifa Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Ariel Rubashkin's experience

Connections

100 +

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies2
ENDYMED LTD

Health Technology

ALLMED SOLUTIONS LTD

Health Technology

Private companies6

Health Technology

Allium Ltd.

Finance

Truleaf Medical Ltd.

Allevetix Medical Ltd.

Health Technology

See company connections
  1. Stock Market
  2. Insiders
  3. Ariel Rubashkin
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW